The presence of BPC-157 might have led to an increased expression of VEGF-a, a variant of VEGF, and consequently accelerated the formation of vascular tubes in a laboratory setting
ive used it for 4 weeks now and the difference is major
15 Amino acid peptide sequence derived from body protective compound Multi Tissue healing supportgut, tendons, ligaments, muscles, and more Questions BPC-157 is administered via subcutaneous injection into the fatty tissue beneath the skin, or in some cases, intramuscularly near the injury site
It is not a licensed medicine, is not approved for human or veterinary use, and must not be administered to any living organism outside a formally approved research protocol
For example, too much L-carnitine can lead to palpitations
Highest documentation standard: FDA-registered manufacturers (Hospira, Fresenius Kabi) with per-lot COAs, NDC-traceable product, and cGMP manufacturing